← TrialMatch
HomeTrials

Psychiatric Multi-omics and Neuroimaging Project

This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in base

Condition(s)Mental Disorders, Healthy Control
StatusRecruiting
Study typeObservational
SummaryThis study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.
Who can participateInclusion Criteria: * Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age) * Course of disease: \<24 months * Priority is given to patients who have never taken medicine or duration of drug use \< 2 weeks * No nuclear magnetic contraindications. Exclusion Criteria: * Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence * Have a major physical disease or infectious disease * History of coma and serious neurological disease 4.MRI contraindications.
Ages13 Years to 35 Years
SexAll
Accepts healthy volunteersYes
Lead sponsormingjun Zhong
LocationsChangsha, Hunan, China
Start date2016-01
NCT IDNCT06580860
Official listinghttps://clinicaltrials.gov/study/NCT06580860

🔍 Search all trials →